Bafna Pharmaceuticals gets UK MHRA approval

MUMBAI: Shares of Bafna Pharmaceuticals moved higher after the company got approval from the UK Medicines and Healthcare products Regulatory Agency ( MHRA) for Finasteride 5 MG tablets.

The scrip was at Rs 48, up 2.02 per cent on the BSE. It touched a high of Rs 51.90 and low of Rs 47.25 in trade so far.